Molecular biology of osteosarcoma

AM Czarnecka, K Synoradzki, W Firlej, E Bartnik… - Cancers, 2020 - mdpi.com
Osteosarcoma (OS) is the most frequent primary bone cancer in children and adolescents
and the third most frequent in adults. Many inherited germline mutations are responsible for …

Review of a new bone tumor therapy strategy based on bifunctional biomaterials

J Liao, R Han, Y Wu, Z Qian - Bone research, 2021 - nature.com
Bone tumors, especially those in osteosarcoma, usually occur in adolescents. The standard
clinical treatment includes chemotherapy, surgical therapy, and radiation therapy …

Current status and prospects of targeted therapy for osteosarcoma

Z Hu, S Wen, Z Huo, Q Wang, J Zhao, Z Wang, Y Chen… - Cells, 2022 - mdpi.com
Osteosarcoma (OS) is a highly malignant tumor occurring in bone tissue with a high
propensity to metastasize, and its underlying mechanisms remain largely elusive. The OS …

Biology and pathogenesis of human osteosarcoma

JWV de Azevedo… - Oncology …, 2020 - spandidos-publications.com
Osteosarcoma (OS) is a bone tumor of mesenchymal origin, most frequently occurring
during the rapid growth phase of long bones, and usually located in the epiphyseal growth …

CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope

V Karn, S Sandhya, W Hsu, D Parashar… - Cancer Cell …, 2022 - Springer
Cancer is one of the major causes of mortality worldwide, therefore it is considered a major
health concern. Breast cancer is the most frequent type of cancer which affects women on a …

Targeted therapy for osteosarcoma: a review

S Li, H Zhang, J Liu, G Shang - Journal of cancer research and clinical …, 2023 - Springer
Background Osteosarcoma is a common primary malignant tumour of the bone that usually
occurs in children and adolescents. It is characterised by difficult treatment, recurrence and …

Mitochondrial DNA mutations in ageing and cancer

ALM Smith, JC Whitehall, LC Greaves - Molecular Oncology, 2022 - Wiley Online Library
Advancing age is a major risk factor for malignant transformation and the development of
cancer. As such, over 50% of neoplasms occur in individuals over the age of 70. The …

Progress of phototherapy applications in the treatment of bone cancer

J Sun, F Xing, J Braun, F Traub, PM Rommens… - International journal of …, 2021 - mdpi.com
Bone cancer including primary bone cancer and metastatic bone cancer, remains a
challenge claiming millions of lives and affecting the life quality of survivors. Conventional …

CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer

J Wang, R Zhang, Z Lin, S Zhang, Y Chen… - Journal of Hematology & …, 2020 - Springer
Background The cyclin-dependent kinase 7 (CDK7) subunit of TFIIH regulates RNA
polymerase-II-based transcription and promotes tumor progression. However, the …

Two hawks with one arrow: A review on bifunctional scaffolds for photothermal therapy and bone regeneration

Y Zhang, X Liu, C Geng, H Shen, Q Zhang, Y Miao… - Nanomaterials, 2023 - mdpi.com
Despite the significant improvement in the survival rate of cancer patients, the total cure of
bone cancer is still a knotty clinical challenge. Traditional surgical resectionof bone tumors is …